2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Files
Publication date
2020-01-01
Authors
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC)
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Apolipoprotein B, Cholesterol, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins, Taverne, Cardiology and Cardiovascular Medicine
Citation
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) 2020, '2019 ESC/EAS Guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk', European heart journal, vol. 41, no. 1, pp. 111-188. https://doi.org/10.1093/eurheartj/ehz455